Molecular characterization of woodchuck type I interferons and their expression by woodchuck peripheral blood lymphocytes

Cytokine

Volumn 41, Issue 2, 2008, Pages 127-135

  Lu, Yinping ^a,b   Xu, Yang ^a,b   Yang, Dongliang ^b   Kemper, Thekla ^a   Roggendorf, Michael ^a   Lu, Mengji ^a,b  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Hepatitis B virus infection; Type I interferon; Woodchuck

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON;

ANIMAL CELL; ARTICLE; CELL STIMULATION; CHRONIC DISEASE; CONTROLLED STUDY; DENDRITIC CELL; ENCEPHALOMYOCARDITIS VIRUS; GENE SEQUENCE; IMMUNE RESPONSE; INFECTION PREVENTION; INTERFERON PRODUCTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN INDUCTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEQUENCE ANALYSIS; WOODCHUCK;

ANIMALS; CELLS, CULTURED; HEPATITIS B VIRUS, WOODCHUCK; INTERFERON TYPE I; LYMPHOCYTES; MARMOTA; MICE; POLY I-C; RESTRICTION MAPPING; SEQUENCE ALIGNMENT;

ENCEPHALOMYOCARDITIS VIRUS; HEPATITIS B VIRUS; MARMOTA MONAX; WOODCHUCK HEPATITIS VIRUS;

EID: 38949147078     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2007.11.002     Document Type: Article

References (37)

1. Vilcek J., and Sen G. Interferons and other cytokines. In: Fields B.N., et al. (Ed). Fields virology. third ed. (1996), Lippincott-Raven, Philadelphia 375-399
2. Stark G.R., Kerr I.M., Williams B.R.G., Silverman R.H., and Schreiber R.D. How cells respond to interferons. Annu Rev Biochem 67 (1998) 227-264
3. Staeheli P. Interferon-induced proteins and the antiviral state. Adv Virus Res 38 (1990) 147-200
4. Uze G., Lutfalla G., and Mogensen K.E. Alpha and beta interferon and their receptor and their friends and relations. J Interferon Cytokine Res 15 (1995) 3-26
5. Horvath C.M. STAT protein and transcriptional responses to extracellular siganls. Trends Biochem Sci 25 (2000) 496-502
6. Darnell Jr. J.E. STATs and gene regulation. Science 277 (1997) 1630-1635
7. Hoofnagle J.H., Peters M., Mullen K.D., Jones D.B., Rustgi V., Di Bisceglie A., et al. Randomized controlled trial of recombinant human alpha-interferon in patients with chronic hepatitis B. Gastroenterology 95 (1998) 1318-1325
8. Serfaty L., Thabut D., Zoulim F., Andreani T., Chazouilleres O., Carbonell N., et al. Sequential treatment with lamivudine and interferon monotherapies in patients with chronic hepatitis B not responding to interferon alone: results of a pilot study. Hepatology 34 (2001) 573-577
9. Janssen H.L., van Zonneveld M., Senturk H., Zeuzem S., Akarca U.S., Cakaloglu Y., et al. Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial. Lancet 365 (2005) 123-129
10. Lau G.K., Piratvisuth T., Luo K.X., Marcellin P., Thongsawat S., Cooksley G., et al. Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B. N Engl J Med 352 (2005) 2682-2695
11. Summers J., Smolec J.M., and Snyder R. A virus similar to human hepatitis B virus associated with hepatitis and hepatoma in woodchucks. Proc Natl Acad Sci USA 75 (1978) 4533-4537
12. Roggendorf M., and Lu M. Woodchuck hepatitis virus. In: Thomas T.H., Zuckermann A., and Lemon S. (Eds). Viral hepatitis. third ed. (2005), Blackwell Publishing Ltd, Oxford
13. Roggendorf M, Lu M. The woodchuck: a model for studies on immunopathogenesis and therapy of hepadnaviral infection. In: von Weizäcker F, Roggendorf M, editors. Models for viral heptitis. Monogr. Virol. Basel: Karger (Review); 2005.
14. Salucci V., Lu M., Aurisicchio L., La Monica N., Roggendorf M., and Palombo F. Expression of a new woodchuck IFN-alpha gene by a helper-dependent adenoviral vector in woodchuck hepatitis virus-infected primary hepatocytes. J Interferon Cytokine Res 22 (2002) 1027-1034
15. Berraondo P., Garcia-Navarro R., Gonzalez-Aseguinolaza G., Vales A., Blanco-Urgoiti B., Larrea E., et al. The woodchuck interferon-alpha system: cloning, family description, and biologic activity. J Med Virol 68 (2002) 424-432
16. Fiedler M., Rodicker F., Salucci V., Lu M., Aurisicchio L., Dahmen U., et al. Helper-dependent adenoviral vector-mediated delivery of woodchuck-specific genes for alpha interferon (IFN-alpha) and IFN-gamma: IFN-alpha but not IFN-gamma reduces woodchuck hepatitis virus replication in chronic infection in vivo. J Virol 78 (2004) 10111-10121
17. Berraondo P., Ochoa L., Crettaz J., Rotellar F., Vales A., Martinez-Anso E., et al. IFN-alpha gene therapy for woodchuck hepatitis with adeno-associated virus: differences in duration of gene expression and antiviral activity using intraportal or intramuscular routes. Mol Ther 12 (2005) 68-76
18. Duan X.Z., Wang M., Li H.W., Zhuang H., Xu D., and Wang F.S. Decreased frequency and function of circulating plasmocytoid dendritic cells (pDC) in hepatitis B virus infected humans. J Clin Immunol 24 (2004) 637-646
19. Wang B., Lohrengel B., Lu Y., Meng Z., Xu Y., Yang D.L., et al. Molecular characterization of woodchuck IL15 and its intrahepatic expression in WHV-infected woodchucks. Cytokine 32 (2006) 296-303
20. Lu M., Lohrengel B., Hilken G., Kemper T., and Roggendorf M. Woodchuck gamma interferon upregulates major histocompatibility complex class I transcription but is unable to inhibit the woodchuck hepatitis virus (WHV) replication in persistently WHV-infected woodchuck primary hepatocytes. J Virol 76 (2002) 58-67
21. Yang D., Lu M., Hao L., and Roggendorf M. Molecular cloning and characterization of major histocompatibility complex class I cDNAs from woodchuck Woodchuck MHC class I. Tissue Antigens 55 (2000) 548-557
22. Abb J., Zachoval R., Eisenburg J., Pape G.R., Zachoval V., and Deinhardt F. Production of interferon alpha and interferon gamma by peripheral blood leukocytes from patients with chronic hepatitis B virus infection. J Med Virol 16 (1985) 171-176
23. Wang F.S., Xing L.H., Liu M.X., Zhu C.L., Liu H.G., Wang H.F., et al. Dysfunction of peripheral blood dendritic cells from patients with chronic hepatitis B virus infection. World J Gastroenterol 7 (2001) 537-541
24. Lohr H.F., Pingel S., Bocher W.O., Bernhard H., Herzog-Hauff S., Rose-John S., et al. Reduced virus specific T helper cell induction by autologous dendritic cells in patients with chronic hepatitis B-restoration by exogenous interleukin-12. Clin Exp Immunol 130 (2002) 107-114
25. Beckebaum S., Cicinnati V.R., Zhang X., Ferencik S., Frilling A., Grosse-Wilde H., et al. Hepatitis B virus-induced defect of monocyte-derived dendritic cells leads to impaired T helper type 1 response in vitro: mechanisms for viral immune escape. Immunology 109 (2003) 487-495
26. Arima S., Akbar S.M., Michitaka K., Horiike N., Nuriva H., Kohara M., et al. Impaired function of antigen-presenting dendritic cells in patient with chronic hepatitis B: localization of HBV DNA and HBV RNA in blood DC by in situ hybridization. Int J Mol Med 11 (2003) 169-174
27. Zheng B.J., Zhou J., Qu D., Siu K.L., Lam T.W., Lo H.Y., et al. Selective functional deficit in dendritic cell-T cell interaction is a crucial mechanism in chronic hepatitis B virus infection. J Viral Hepatol 11 (2004) 217-224
28. Jilbert A.R., Burrell C.J., Gowans E.J., Hertzog P.J., Linnane A.W., and Marmion B.P. Cellular localization of alpha-interferon in hepatitis B virus-infected liver tissue. Hepatology 6 (1986) 957-961
29. Nouri-Aria K.T., Arnold J., Davison F., Portmann B.C., Meager A., Morris A.G., et al. Hepatic interferon-alpha gene transcripts and products in liver specimens from acute and chronic hepatitis B virus infection. Hepatology 13 (1991) 1029-1034
30. Fang J.W., Wu P.C., Lai C.L., Lo C.K., Meager A., and Lau J.Y. Hepatic expression of interferon-alpha in chronic hepatitis B virus infection. Dig Dis Sci 39 (1994) 2014-2021
31. Leifeld L., Ramakers J., Schneiders A.M., Dumoulin F.L., Sterneck M., Muller A., et al. Intrahepatic MxA expression is correlated with interferon-alpha expression in chronic and fulminant hepatitis. J Pathol 194 (2001) 478-483
32. Ito T., Kanzler H., Duramad O., Cao W., and Liu Y.J. The specialization, kinetics, and repertoire of type I interferon responses by human plasmacytoid pre-dendritic cells. Blood 107 (2006) 2423-2431
33. Kadowaki N., Ho S., Antonenko S., Malefyt R.W., Kastelein R.A., Bazan F., et al. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med 194 (2001) 863-869
34. Kadowaki N., Antonenko S., and Liu Y.J. Distinct CpG DNA and polyinosinic-polycytidylic acid double-stranded RNA, respectively, stimulate CD11c- type 2 dendritic cell precursors and CD11c+ dendritic cells to produce type I IFN. J Immunol 166 (2001) 2291-2295
35. Jarrossay D., Napolitani G., Colonna M., Sallusto F., and Lanzavecchia A. Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells. Eur J Immunol 31 (2001) 3388-3393
36. James C.M., Abdad M.Y., Mansfield J.P., Jacobsen H.K., Vind A.R., Stumbles P.A., et al. Differential activities of alpha/beta IFN subtypes against influenza virus in vivo and enhancement of specific immune responses in DNA vaccinated mice expressing haemagglutinin and nucleoprotein. Vaccine 25 (2007) 1856-1867
37. Cull V.S., Tilbrook P.A., Bartlett E.J., Brekalo N.L., and James C.M. Type I interferon differential therapy for erythroleukemia: specificity of STAT activation. Blood 101 (2003) 2727-2735